CTOs on the Move

BayCare Clinic

www.baycareclinic.com

 
BayCare Clinic is a physician-owned specialty care clinic based in Green Bay, Wisconsin, that offers expertise in more than 20 specialties with over 100 physicians serving in 16 area communities. BayCare Clinic is a joint partner in Aurora BayCare Medi...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

LaBelle Strategic Resources

LaBelle Strategic Resources is a Collegeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

21st Century Scientific

21st Century Scientific is a Coeur D Alene, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeSpire of Virginia

LifeSpire of Virginia operates five life plan communities throughout Virginia: The Chesapeake in Newport News, The Culpeper in Culpeper, The Glebe in Daleville, Lakewood in Richmond and The Summit in Lynchburg. The organization, a faith-based nonprofit, has served Virginia`s seniors for more than 70 years. Each LifeSpire community provides a full continuum of care to address the changing health needs of seniors. Readily accessible assisted living, 24-hour nursing care, physical therapy and memory support services give residents and their loved ones peace of mind knowing team members are always available to provide excellent service and care.

Fulcrum Health

Leveraging physical medicine to transform health care.

Clarvista Medical

ClarVista Medical` based in Aliso Viejo` California is a leading developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing` ClarVista was spun out from Prospex Medical` a medical device incubator` to pursue the development of the HARMONI™ IOL. Between 2012 and 2014` the company developed the first generation HARMONI™ system` conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system` conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.